Effects of depo-medroxyprogesterone acetate as a contraceptive agent
Powell, L.C.; Seymour, R.J.
American Journal of Obstetrics and Gynecology 110(1): 36-41
1971
ISSN/ISBN: 0002-9378 PMID: 5573607 DOI: 10.1016/0002-9378(71)90210-9Document Number: 482715
Document emailed within 0-6 h
Related Documents
Jeppsson, S. 1972: Experience with depo-medroxyprogesterone acetate (Depo-Provera) as a contraceptive agent Acta Obstetricia et Gynecologica Scandinavica 51(3): 257-263Jeppsson, S. 1972: Experience with depo-medroxyprogesterone acetate (Depo-Provera) as a contraceptive agent Acta Obstetricia et Gynecologica Scandinavica 51(3): 257-263
Jeppsson, S. 1972: Experience with depo-medroxyprogesterone acetate (Depo-Provera) as a contraceptive agent Acta Obstetricia et Gynecologica Scandinavica 51(3): 257-263
Jeppsson, S.; Gershagen, S.; Johansson, E. D. B.; Rannevik, G. 1982: Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera(R)) as a contraceptive agent European Journal of Endocrinology 99(3): 339-343
Soichet, S. 1969: Depo-provera (medroxyprogesterone acetate) as a female contraceptive agent International Journal of Fertility 14(1): 33-38
Bloch, B. 1971: Depot medroxyprogesterone acetate (Depo-Provera) as a contraceptive preparation South African Medical Journal 45(28): 777-780
Cromer, B.A.; Smith, R.D.; Blair, J.M.; Dwyer, J.; Brown, R.T. 1994: A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception Pediatrics 94(5): 687-694
Linthorst, G.; Wibaut, E.P.; de Jongh, R.E. 1972: Experiences with a 3-monthly injections of medroxyprogesterone acetate (MPA) as a contraceptive agent Nederlands Tijdschrift Voor Geneeskunde 116(38): 1694-1698
Mettler, L.; Shirwani, D.; Brunnberg, F.J. 1979: Thombocyte function in relation to the long term application of medroxyprogesterone acetate as a female contraceptive agent Journal of Postgraduate Medicine 25(3): 154-157
Sturm, G.; Antal, E.; Schmidt Rhode, P.; Bauer, T.; Schulz K D. 1986: Medroxyprogesterone acetate and immunoreactive medroxyprogesterone acetate metabolites measured by two different selective radioimmunoassay antibodies in medroxyprogesterone acetate treated breast cancer patients Anticancer Research 6(3 Part A): 362
Cromer, B. 2005: In favor of continued use of depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents Journal of Pediatric and Adolescent Gynecology 18(3): 183-187
Ozgoli, G.; Sheikhan, Z.; Dolatian, M.; Simbar, M.; Bakhtyari, M.; Nasiri, M. 2015: Comparison of Sexual Dysfunction in Women Using Depo-Medroxyprogesterone Acetate (DMPA) and Cyclofem Journal of Reproduction and Infertility 16(2): 102-108
Cromer, B. 2005: In favor of continued use of depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents Journal of Pediatric and Adolescent Gynecology 18(3): 183-187
Omar, H.; Kives, S. 2005: Depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents: what is next after the FDA black box warning Journal of Pediatric and Adolescent Gynecology 18(3): 183
Omar, H.; Kives, S. 2005: Depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents: what is next after the FDA black box warning Journal of Pediatric and Adolescent Gynecology 18(3): 183
Cromer, B. 2005: In favor of continued use of depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents Journal of Pediatric and Adolescent Gynecology 18(3): 183-187
Omar, H.; Kives, S. 2005: Depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents: what is next after the FDA black box warning Journal of Pediatric and Adolescent Gynecology 18(3): 183
Siriwongse, T.; Snidvongs, W.; Tantayaporn, P.; Leepipatpaiboon, S. 1982: Effect of depo-medroxyprogesterone acetate on serum progesterone levels when administered on various cycle days Contraception 26(5): 487-493
Piver, M.S.; Barlow, J.J.; Lurain, J.R.; Blumenson, L.E. 1980: Medroxyprogesterone acetate (Depo-Provera) vs. hydroxyprogesterone caproate (Delalutin) in women with metastatic endometrial adenocarcinoma Cancer 45(2): 268-272
Barnes, R.B.; Roy, S.; Lobo, R.A. 1985: Comparison of lipid and androgen levels after conjugated estrogen or depo-medroxyprogesterone acetate treatment in postmenopausal women Obstetrics and Gynecology 66(2): 216-219